Chemours expands ion exchange materials
Chemours is to invest $200 million to increase capacity and advance technology for its Nafion brand ion exchange materials at the site in Villers-Saint-Paul, France. The investment is subject to obtaining the necessary permits and licences for construction and operations. It includes ionomers and associated membranes.
Mark Newman, president and CEO, commented: “Chemours has chosen France for this investment in the hydrogen economy because of the strong alignment between our sustainable growth vision, the French government’s goal to create a reliable and strong hydrogen economy and the EU’s ambition to deliver a clean energy transition based on the objectives set in the EU Climate Law.”
RELATED ARTICLES
Travertine Technologies and precious metal refiner Sabin Metal have announced plans have revealed plans to build a demonstration plant at Sabin’s main facility near Rochester, New York.
Two CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.
OCSiAl has opened its first European graphene nanotubes facility in Serbia. It will produce 60 tonnes/year under the Tuball band and the company plans to double this by launching a second synthesis unit within the next year. The modular design means it is able to scale production rapidly.
A pilot enforcement project carried out by national enforcement authorities in 13 European Economic Area (EEA) countries between November 2023 and April 2024 found that 6% of about 4,500 cosmetic products inspected contained hazardous substances.
Biosynth, which supplies critical raw materials and services for diagnostics, vaccines and pharmaceuticals, has officially opened its Biosynth Biological Technology site at Lifebay, a technology park in Suzhou, China.
Spanish energy and chemicals company Cepsa has renamed itself Moeve.
